Take Action to Prevent Diabetes – The IMAGE Toolkit for the Prevention of Type 2 Diabetes in Europe

Lindström, Jaana; Neumann, Anne; Sheppard, Kate; Gilis‐Januszewska, Aleksandra; Greaves, Colin; Handke, Ulrich; Pajunen, Pia; Puhl, Sabine; Pölönen, Auli; Rissanen, Aila; Roden, Michael; Stemper, T.; Telle-Hjellset, V.; Tuomilehto, Jaakko; Veličkienė, Džilda; Schwarz, Peter E. H.; Acosta, Tania Bravo; Adler, M.; Alkerwi, Ala’a; Barengo, Noël C.; Barengo, R; Boavida, J. M.; Charlesworth, Kate; Christov, V.; Claussen, Bjørgulf; Cos, Xavier; Cosson, E.; Deceukelier, S.; Dimitrijević-Srećković, V.; Djordjević, Predrag; Evans, Philip; Felton, Anne; Fischer, María Isabel; Gabriel-Sánchez, R.; Goldfracht, Margalit; Gomez, J. L.; Hall, Michael Stephen; Hauner, Hans; Herbst, Jeffrey H.; Hermanns, Norbert; Herrebrugh, L.; Huber, Claudia; Hühmer, U.; Huttunen, Jussi K.; Jotić, Aleksandra; Kamenov, Zdravko; Karadeniz, S.; Katsilambros, Nikolaos; Khalangot, Mykola; Kissimova-Skarbek, Katarzyna; Köhler, D.; Kopp, Vincent J.; Kronsbein, Peter; Kulzer, Bernhard; Kyne-Grzebalski, D.; Lalić, K.; Lalić, Nebojša; Landgraf, R.; Lee-Barkey, YH; Liatis, Stavros; Makrilakis, Konstantinos; McIntosh, C.; McKee, Martin; Mesquita, Ana Cristina; Misina, D.; Muylle, F.; Paiva, Anabela; Paulweber, Bernhard; Peltonen, Markku; Perrenoud, Luz; Pfeiffer, Andreas F. H.; Raposo, Falcão; Reinehr, T.; Robinson, Chris; Rothe, Ulrike; Saaristo, Timo; Scholl, Jamie L.; Spiers, S.; Stratmann, Bernd; Szendroedi, J; Szybiński, Z; Tankova, Tsvetalina; Terry, G.; Tolks, Daniel; Toti, Florian; Undeutsch, A.; Valadas, Cristina; Valensi, P.; Vermunt, P.; Weiss, Ram; Wens, Johan; Yılmaz, Temel

doi:10.1055/s-0029-1240975

Cited by 207 publications

(174 citation statements)

References 15 publications

Supporting

Mentioning

149

Contrasting

Unclassified

Order By: Relevance

“…24,25 Evidence-based practical guidelines for diabetes prevention have been published, derived from a large European initiative. 26 Furthermore, there was a review summarizing risk factors for diabetes risk. 27 Such tools are extremely important for the prevention of diabetes, but their applicability in Asian Indian populations needs to be studied.…”

Section: Discussionmentioning

confidence: 99%

A Simple Indian Diabetes Risk Score Could Help Identify Nondiabetic Individuals at High Risk of Non-Alcoholic Fatty Liver Disease (CURES-117)

Anbalagan

Venkataraman

Vamsi

et al. 2012

J Diabetes Sci Technol

View full text Add to dashboard Cite

Abbreviations: (ALT) alanine aminotransferase, (AST) aspartate aminotransferase, (BMI) body mass index, (CURES) Chennai Urban Rural Epidemiology Study, (HbA1c) glycated hemoglobin, (HDL) high-density lipoprotein, (HOMA-IR) homeostasis assessment model for insulin resistance, (IDRS) Indian diabetes risk score, (LDL) low-density lipoprotein, (NAFLD) non-alcoholic fatty liver disease, (NASH) non-alcoholic steatohepatitis, (NCD) noncommunicable disease, (OR) odds ratio

show abstract

Section: Discussionmentioning

confidence: 99%

A Simple Indian Diabetes Risk Score Could Help Identify Nondiabetic Individuals at High Risk of Non-Alcoholic Fatty Liver Disease (CURES-117)

Anbalagan

Venkataraman

Vamsi

et al. 2012

J Diabetes Sci Technol

View full text Add to dashboard Cite

show abstract

“…20% (which may be revised down shortly to 10%) or established CVD) [2e4, 8,9,11,15]. The recommended first-line treatment for the majority of patients with raised LDL-C is lifestyle modification to include a Mediterranean-type diet, regular exercise, smoking cessation, and weight loss [2e4, 8,9,11,15,17,53,55,57]. In addition, statins should be prescribed for all high-to veryhigh risk patients that fail to achieve their recommended LDL-C target using non-pharmacological interventions [2e4, 8,9,11,15,53,55,57] and, according to the 2013 ESC/ EASD Guidelines for Diabetes, Pre-diabetes and CVDs, for all patients with T2D and high CV risk, irrespective of their baseline LDL-C level [8].…”

Section: Guidelines For the Management Of Dyslipidaemia And Cvdmentioning

confidence: 99%

“…smoking, insufficient exercise, and a high-fat, highrefined sugar diet comprising a large proportion of processed food) suggests that greater efforts are needed at every level (including Governmental policies targeted at the food industry) to encourage lifestyle changes. A tool kit providing practical advice for healthcare professionals has recently been developed to aid this process [8,17].…”

Section: Introductionmentioning

confidence: 99%

The use of statins in people at risk of developing diabetes mellitus: Evidence and guidance for clinical practice

Sattar¹,

Ginsberg

Ray

et al. 2014

Atherosclerosis Supplements

View full text Add to dashboard Cite

Reducing low-density lipoprotein cholesterol (LDL-C) levels using statins is associated with significant reductions in cardiovascular (CV) events in a wide range of patient populations. Although statins are generally considered to be safe, recent studies suggest they are associated with an increased risk of developing Type 2 diabetes (T2D). This led the US Food and Drug Administration (FDA) to change their labelling requirements for statins to include a warning about the possibility of increased blood sugar and HbA1c levels and the European Medicines Agency (EMA) to issue guidance on a small increased risk of T2D with the statin class. This review examines the evidence leading to these claims and provides practical guidance for primary care physicians on the use of statins in people with or at risk of developing T2D. Overall, evidence suggests that the benefits of statins for the reduction of CV risk far outweigh the risk of developing T2D, especially in individuals with higher CV risk. To reduce the risk of developing T2D, physicians should assess all patients for T2D risk prior to starting statin therapy, educate patients about their risks, and encourage risk-reduction through lifestyle changes. Whether some statins are more diabetogenic than others requires further study. Statin-treated patients at high risk of developing T2D should regularly be monitored for changes in blood glucose or HbA1c levels, and the risk of conversion from pre-diabetes to T2D should be reduced by intensifying lifestyle changes. Should a patient develop T2D during statin treatment, physicians should continue with statin therapy and manage T2D in accordance with relevant national guidelines.

show abstract

“…The need for tailoring interventions, in particular for different cultural and ethnic groups, has been highlighted by both the IMAGE Toolkit for diabetes prevention [50] and the Diabetes Prevention Program [51].…”

Section: Adoptionmentioning

confidence: 99%

Can physical activity interventions for adults with type 2 diabetes be translated into practice settings? A systematic review using the RE-AIM framework

Matthews

Kirk

MacMillan

et al. 2013

Behav. Med. Pract. Policy Res.

View full text Add to dashboard Cite

Despite the strong evidence base for the efficacy of physical activity in the management of type 2 diabetes, a limited number of physical activity interventions have been translated and evaluated in everyday practice. This systematic review aimed to report the findings of studies in which an intervention, containing physical activity promotion as a component, has been delivered within routine diabetes care. A comprehensive search was conducted for articles reporting process data relating to components of the RE-AIM (Reach, Effectiveness, Adoption, Implementation and/or Maintenance) framework. Twelve studies met the selection criteria. Of the nine studies which measured physical activity as an outcome, eight reported an increase in physical activity levels, five of which were significant. Tailoring recruitment, resources and intervention delivery to the target population played a positive role, in addition to the use of external organisations and staff training. Many interventions were of short duration and lacked long-term follow-up data. Findings revealed limited and inconsistent reporting of useful process data.

show abstract

Take Action to Prevent Diabetes – The IMAGE Toolkit for the Prevention of Type 2 Diabetes in Europe

Cited by 207 publications

References 15 publications

A Simple Indian Diabetes Risk Score Could Help Identify Nondiabetic Individuals at High Risk of Non-Alcoholic Fatty Liver Disease (CURES-117)

A Simple Indian Diabetes Risk Score Could Help Identify Nondiabetic Individuals at High Risk of Non-Alcoholic Fatty Liver Disease (CURES-117)

The use of statins in people at risk of developing diabetes mellitus: Evidence and guidance for clinical practice

Can physical activity interventions for adults with type 2 diabetes be translated into practice settings? A systematic review using the RE-AIM framework

Contact Info

Product

Resources

About